Responsiveness and clinically important differences for the WOMAC and SF-36 after hip joint replacement J.M. Quintana, Ph.D., A. Escobar, M.D., A. Bilbao, M.Sc., I. Arostegui, M.H.Sc., I. Lafuente, M.Sc., I. Vidaurreta, M.D. Osteoarthritis and Cartilage Volume 13, Issue 12, Pages 1076-1083 (December 2005) DOI: 10.1016/j.joca.2005.06.012 Copyright © 2005 OsteoArthritis Research Society International Terms and Conditions
Fig. 1 Patient recruitment and losses. Patients were excluded if their main diagnosis was not hip OA; if they had malignant, severe organic, or psychiatric diseases; or if they did not undergo surgical intervention, for any reason (death, intervention in other hospital, refusal of the intervention), 1 year after inclusion in the study. Each percentage (in parentheses) is estimated based on the previous frequency except for response rate at 2 years, which was based on the 469 patients who entered the study. Osteoarthritis and Cartilage 2005 13, 1076-1083DOI: (10.1016/j.joca.2005.06.012) Copyright © 2005 OsteoArthritis Research Society International Terms and Conditions
Fig. 2 Changes in normalized SF-36 values. SF-36 domains: PF: physical function; RP: role physical; BP: bodily pain; GH: general health; SF: social function; RE: role emotional; VT: vitality; MH: mental health. 50: reference score of general population older than 45 years. Osteoarthritis and Cartilage 2005 13, 1076-1083DOI: (10.1016/j.joca.2005.06.012) Copyright © 2005 OsteoArthritis Research Society International Terms and Conditions